リウマチ学: 現在の研究
オープンアクセス

概要

Rheumatologists

Amit P. Ladani

The rheumatology community has been confronted with many challenges during the COVID-19 pandemic. Early in the pandemic, there were questions about managing rheumatic immunosuppressive medications, while of late, it has been about the COVID-19 vaccine. As the pandemic continues to evolve, and more high-quality studies are available to answer pressing questions, many unknowns remain. This summary attempts to provide a viewpoint from a Rheumatologists’ angle about the current landscape of COVID-19.